Equal metabolic control but superior caregiver treatment satisfaction with insulin aspart in preschool children

Diabetes Technology and Therapeutics

Volumn 12, Issue 5, 2010, Pages 413-418

  Pańkowska, Ewa ^a   Nazim, Joanna ^b   Szalecki, Mieczysław ^c   Urban, Miroslawa ^d  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c Specialist Paediatric Hospital   (Poland)

^d MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN; INSULIN ASPART; ISOPHANE INSULIN; NEUTRAL INSULIN;

ARTICLE; CHILD; CLINICAL EVALUATION; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; GASTROINTESTINAL SYMPTOM; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; METABOLIC REGULATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; QUESTIONNAIRE; SAFETY; SATISFACTION; SCHOOL CHILD; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION;

CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; PATIENT SATISFACTION; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 77951123850     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/dia.2009.0155     Document Type: Article

References (29)

1. Scholtz H, van Niekerk N, Meyer B: An assessment of the variability in the pharmacodynamics (glucose lowering effect) of HOE901 compared to NPH and ultralente human insulins using the euglycemic clamp technique [abstract 882]. Diabetologia 1999;42(Suppl 1):882.
2. Mortensen HB, Lindholm A, Olsen BS, Hylleberg B: Rapid appearance and onset of action of insulin aspart in paediatric subjects with type 1 diabetes. Eur J Paediatrics 2000;159:483-488.
3. Lindholm A, McEwen J, Riis AP: Improved postprandial glycemic control with insulin aspart. A randomized doubleblind cross-over trial in type 1 diabetes. Diabetes Care 1999; 22:801-805.
4. Home PD, Lindholm A, Riis A; European Insulin Aspart Study Group: Insulin aspart vs. human insulin in the management of long-term blood glucose control in type 1 diabetes mellitus: a randomized controlled trial. Diabet Med 2000;17:762-770.
5. Home PD, Lindholm A, Hylleberg B, Round P; U.K Insulin Aspart Study Group: Improved glycemic control with insulin aspart. Diabetes Care 1998;21:1904-1909.
6. Raskin P, Guthrie RA, Leiter L, Riis A, Jovanovic L: Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes. Diabetes Care 2000;23:583-588.
7. Rosenfalck AM, Thorsby P, Kjems L, Birkeland K, Dejgaard A, Hanssen KF, Madsbad S: Improved postprandial glycemic control with insulin aspart in type 2 diabetic patients treated with insulin. Acta Diabetol 2000;37:41-46.
8. Heller SR, Colagiuri S, Vaaler S, Wolffenbuttel BH, Koelendorf K, Friberg HH, Windfeld K, Lindholm A: Hypoglycemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with type 1 diabetes. Diabet Med 2004;21:769-775.
9. Brunner GA, Hirschberger S, Sendlhofer G, Wutte A, Ellmerer M, Balent B, Schaupp L, Krejs GJ, Pieber TR: Postprandial administration of the insulin analogue insulin aspart in patients with Type 1 diabetes mellitus. Diabet Med 2000;17:371-375.
10. Weinzimer SA, Ahern JH, Doyle EA, Vincent MR, Dziura J, Steffen AT, Tamborlane WV: Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics 2004;114:1601-1605.
11. Ahern JA, Boland EA, Doane R, Ahern JJ, Rose P, Vincent M, Tamborlane WV: Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower A1C levels across all age groups. Pediatr Diabetes 2002;3:10-15.
12. Tubiana-Rufi N, de Lonlay P, Bloch J, Czernichow P: [Remission of severe hypoglycemic incidents in young diabetic children treated with subcutaneous infusion]. Arch Pediatr 1996;3:969-1967
13. Willi SM, Planton J, Egede L, Schwarz S: Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes. J Pediatr 2003;143:796-801.
14. Bode BW, Tamborlane WV, Davidson PC: Insulin pump therapy in the 21st century: strategies for successful use in adults, adolescents and children with diabetes. Postgrad Med 2002;111:69-77.
15. Bode BW, Strange P: Efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes. Diabetes Care 2001;24:69-72.
16. Hoogma RP, Schumicki D: Safety of insulin glulisine when given by continuous subcutaneous infusion using an external pump in patients with type 1 diabetes. Horm Metab Res 2006;38:429-433.
17. Bode B, Steed R, Davidson P: Continuous subcutaneous insulin infusion (CSII): a study comparing lispro to regular human insulin [abstract 167]. Diabetes 1997;46(Suppl 1):43A.
18. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV: Continuous subcutaneous insulin infusion: a new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999;22:1779-1784.
19. Litton J, Rice A, Friedman N, Oden J, Lee MM, Freemark M: Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. J Pediatr 2002;141:490-495.
20. Pańkowska E, Lipka M, Wysocka M, Szypowska A, Trippenbach-Dulska H, Czapliń ska M, Kołodziejska B: Metabolic control in young children with type 1 diabetes treated with continuous subcutaneous insulin infusion (insulin pump) [in Polish]. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 2003;9:11-15.
21. Tsalikian E, Mueller P: Insulin aspart in paediatric and adolescent patients with type 1 diabetes. Diabetalogia 2000;43 (Suppl 1):A200.
22. Bradley C: Diabetes treatment satisfaction questionnaire. In: Bradley C, ed. Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in Diabetes Research and Practice. Chur, Switzerland: Harwood Academic, 1994:111-132.
23. Danne T, Råstam J, Odendahl R, Näke A, Schimmel U, Szczepanski R, Moeller J, Deiss D: Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes. Pediatr Diabetes 2007;8:278-285.
24. DiMeglio LA, Pottorff TM, Boyd SR, France L, Fineberg N, Eugster EA: A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr 2004;145:380-384.
25. Fox LA, Buckloh LM, Smith SD, Wysocki T, Mauras N: A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care 2005;28:1277-1281.
26. Wilson DM, Buckingham BA, Kunselman EL, Sullivan MM, Paguntalan HU, Gitelman SE: A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care 2005;28:15-19.
27. Bougnères PF, Landier F, Lemmel C, Mensire A, Chaussain JL: Insulin pump therapy in young children with type 1 diabetes. J Pediatr 1984;105:212-217.
28. Danne T, Mortensen HB, Hougaard P, Lynggaard H, Aanstoot HJ, Chiarelli F, Daneman D, Dorchy H, Garandeau P, Greene SA, Hoey H, Holl RW, Kaprio EA, Kocova M, Martul P, Matsuura N, Robertson KJ, Schoenle EJ, Søvik O, Swift PG, Tsou RM, Vanelli M, Aman J; Hvidøre Study Group on Childhood Diabetes: Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group. Diabetes Care 2001;24: 1342-1347.
29. Davis EA, Keating B, Byrne GC, Russell M, Jones TW: Hypoglycemia: incidence and clinical predictors in a large population based sample of children and adolescents with IDDM. Diabetes Care 1997;20:22-25.